218 related articles for article (PubMed ID: 34904531)
1. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit.
Lin XB; Huang F; Tong L; Xia YZ; Wu JJ; Li J; Hu XG; Liang T; Liu XM; Zhong GP; Cai CJ; Chen X
Int J Infect Dis; 2020 Apr; 93():345-352. PubMed ID: 32109625
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J; Choi JH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
[TBL] [Abstract][Full Text] [Related]
6. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review.
Jendoubi A; Pressiat C; De Roux Q; Hulin A; Ghaleh B; Tissier R; Kohlhauer M; Mongardon N
Int J Antimicrob Agents; 2024 Feb; 63(2):107078. PubMed ID: 38161046
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
Van Daele R; Brüggemann RJ; Dreesen E; Depuydt P; Rijnders B; Cotton F; Fage D; Gijsen M; Van Zwam K; Debaveye Y; Wauters J; Spriet I
J Antimicrob Chemother; 2021 Apr; 76(5):1234-1241. PubMed ID: 33517360
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.
Lyster H; Shekar K; Watt K; Reed A; Roberts JA; Abdul-Aziz MH
Clin Pharmacokinet; 2023 Jul; 62(7):931-942. PubMed ID: 37300631
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
Ha MA; Sieg AC
Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
[TBL] [Abstract][Full Text] [Related]
10. Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report.
Peterson EL; Chittick PJ; Richardson CL
Transpl Infect Dis; 2021 Jun; 23(3):e13545. PubMed ID: 33316840
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Levkovich BJ; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Roberts JA; Shekar K; Fraser JF;
Anaesth Crit Care Pain Med; 2022 Jun; 41(3):101080. PubMed ID: 35472580
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.
Lin XB; Lui KY; Guo PH; Liu XM; Liang T; Hu XG; Tong L; Wu JJ; Xia YZ; Chen P; Zhong GP; Chen X; Cai CJ
Pharmacotherapy; 2022 Jan; 42(1):23-33. PubMed ID: 34655497
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
Mathieu A; Thiboutot Z; Ferreira V; Benoit P; Grandjean Lapierre S; HÉtu PO; Halwagi A
ASAIO J; 2022 Mar; 68(3):e56-e58. PubMed ID: 33788798
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
[TBL] [Abstract][Full Text] [Related]
15. Ceftriaxone Pharmacokinetics and Pharmacodynamics in 2 Pediatric Patients on Extracorporeal Membrane Oxygenation Therapy.
Cervantes FC; Mizuno T; Dong M; Tang P; Arbough T; Vinks AA; Kaplan JM; Tang Girdwood SC
Ther Drug Monit; 2023 Dec; 45(6):832-836. PubMed ID: 37725684
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetics of Levosimendan and its Metabolites in Critically Ill Neonates and Children Supported or Not by Extracorporeal Membrane Oxygenation.
Bourgoin P; Lecomte J; Oualha M; Berthomieu L; Pereira T; Davril E; Lamoureux F; Joram N; Chenouard A; Duflot T
Clin Pharmacokinet; 2023 Feb; 62(2):335-348. PubMed ID: 36631687
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study.
Ronda M; Llop-Talaveron JM; Fuset M; Leiva E; Shaw E; Gumucio-Sanguino VD; Diez Y; Colom H; Rigo-Bonnin R; Puig-Asensio M; Carratalà J; Padullés A
Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508196
[TBL] [Abstract][Full Text] [Related]
18. Fluctuating Voriconazole Concentrations during Extracorporeal Membrane Oxygenation.
Vu T; Feih J; Juul J
J Pharm Pract; 2023 Aug; 36(4):998-1001. PubMed ID: 35612553
[TBL] [Abstract][Full Text] [Related]
19. The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation.
Ye Q; Wang Q; Chen W; Zhang R; Chen Z; Li P; Zhang X; Zhan Q; Wang C
J Clin Pharm Ther; 2022 Oct; 47(10):1608-1618. PubMed ID: 35716048
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0137721. PubMed ID: 34633852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
